Metformin and incretin-based therapies up-regulate central and peripheral Adenosine monophosphate-activated protein affecting appetite and metabolism

二甲双胍和基于肠促胰素的疗法可上调中枢和外周腺苷酸活化蛋白，从而影响食欲和代谢。